• Innovent to develop & commercialize a novel diabetes medicine in China biospectrumasia
    August 22, 2019
    Innovent Biologics, Inc., a world-class biopharmaceutical company that develops and commercializes high-quality medicines, has announced that it has entered into a licensing agreement with Eli Lilly and Company (Lilly) for the development and potential co
PharmaSources Customer Service